SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-20-030629
Filing Date
2020-10-08
Accepted
2020-10-08 16:05:35
Documents
1
Period of Report
2020-06-09
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 8-K ea127915-8ka1_protarathera.htm 8-K/A 25866
  Complete submission text file 0001213900-20-030629.txt   27118
Mailing Address 1 LITTLE WEST 12TH STREET NEW YORK NY 10014
Business Address 1 LITTLE WEST 12TH STREET NEW YORK NY 10014 646-844-0337
Protara Therapeutics, Inc. (Filer) CIK: 0001359931 (see all company filings)

IRS No.: 204580525 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36694 | Film No.: 201231055
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences